(Q54549770)

31 May 2018

title

Prazosin in the treatment of severe chronic congestive cardiac failure. (English)

1 reference

31 May 2018

author name string

Hockings BE

1

1 reference

31 May 2018

Cope GD

2

1 reference

31 May 2018

Clarke GM

3

1 reference

31 May 2018

Taylor RR

4

1 reference

31 May 2018

publication date

1 August 1980

1 reference

31 May 2018

Australian and New Zealand journal of medicine

published in

1 reference

31 May 2018

volume

10

1 reference

31 May 2018

issue

4

1 reference

31 May 2018

page(s)

420-425

1 reference

31 May 2018

Effects of prazosin on forearm resistance and capacitance vessels

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1980.TB04093.X

Efficacy of ambulatory systemic vasodilator therapy with oral prazosin in chronic refractory heart failure. Concomitant relief of pulmonary congestion and elevation of pump output demonstrated by improvements in symptomatology, exercise tolerance, h

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1980.TB04093.X

Hemodynamic effects of orally administered isosorbide dinitrate in patients with congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1980.TB04093.X

Physiologic evaluation of a new antihypertensive agent: prazosin HCl

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1980.TB04093.X

Hemodynamic and clinical tachyphylaxis to prazosin-mediated afterload reduction in severe chronic congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1980.TB04093.X

10.1111/J.1445-5994.1980.TB04093.X

21 January 2018

Identifiers

DOI

1 reference

31 May 2018

1 reference

31 May 2018